FDA Unlikely To Act Unilaterally To Increase ClinicalTrials.gov Postings

FDA believes it has the authority to independently post clinical study information on ClinicalTrials.gov, but does not plan to create a systematic process for increasing the number of industry-sponsored trials listed on the site